Comprehensive Drug Enterprises Ltd - Company Review
Comprehensive Drug Enterprises Ltd - Company ReviewSummary
Comprehensive Drug Enterprises Ltd (CDE), a subsidiary of Athenex Inc is a specialty pharmaceutical company that research, develops, and commercializes advanced drugs and medical devices. The company develops and manufactures products for topical wounds, tremors, and discomfort. Its drug candidates include MJ antipruritic hydrogel for scar-related intractable pruritus; averti for motion sickness; intranasal granisetron for nausea and vomiting in cancer therapies and surgery; and MLS-03 for management of insomnia. CDE collaborates with universities for its research and development activities. The company also offers an oral solution for motion sickness. It has medical device production facility in Chongqing. CDE is headquartered in Hong Kong.
This comprehensive company report of Comprehensive Drug Enterprises Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.